Connor, Clark & Lunn Investment Management (CC&L)
VYNE icon

Connor, Clark & Lunn Investment Management (CC&L)’s VYNE Therapeutics VYNE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,344
Closed -$211K – 1233
2021
Q2 		$211K Buy
+3,344
New +$211K ﹤0.01% 908
2021
Q1 		– Sell
-3,613
Closed -$411K – 1104
2020
Q4 		$411K Buy
3,613
+832
+30% +$94.6K ﹤0.01% 747
2020
Q3 		$332K Buy
+2,781
New +$332K ﹤0.01% 779